77

Literaturverzeichnis

1. ALTMAN E, CADMAN E: "An analyses of 1539 patients with cancer of unknown primary site" . Cancer 57: 120-124 , 1986

2. ALTMANNSBERGER M, DROESE M, OSBORN M, WEBER K: "Immunhistologische Klassifizierung von Metastasen bei unbekannem Primärtumor." Pathologe 5 :269-274 , 1984

3. ABRAMS HL, SPIRO R, GOLDSTEIN N. : "Metastases in carcinoma. Analysis of 1000 Autopsied cases." Cancer III , 74 (1950)

4. AZUMI N, BATTIFORA H.: "The distribution of Vimentin and keratin in epithelial and nonepithelial neoplasms." Am J Clin Pathol 88 :286-296 , 1987

5. BARZ H. and BARZ D ".: Zur Verteilung der Metastasen der Lungengeschwülste.II. Einfluß der Tumorhistologie." Arch. Geschwulstforsch . 52 , 561 (1982 )

6. BASSERMANN R., LUDWIG G, HÖLZEL D und EDER M: "Haematogene Organmetastasen - welcher Primärtumor?" Pathologe 5 : 13-20, 1984

7. BATSON OV: "The function of the vertebral veins and their role in the spread of metastasis." Ann. Surg . 112 , 138 (1940 )

8. BATSON OV: "Role of vertebral veins in metastatic processes." Ann. Intern. Med. 16 ;38 (1942)

9. BOENISCH T: "Färbemethoden. In Handbuch immunhistochemischer Färbemethoden." Naish, S.J.(ed), DAKO Corporation , Carpinteria, Kalifornien, USA 1983 ; Bd.II, S.22-27

10. BROWN RW, CAMPAGNA LB, DUNN J.K., CAGLE PT: "Immunhistochemical identification of tumor markers in metastatic adenocarcinoma, a diagnostic adjunct in the determination of primary site." Am J Clin Pathol 1997 ;107 :12-19

11. CATTORETTI G, PILERI S, PARAVICINI C, BECKER MHG, POGGI S, BIFULCO C, KEY G, D‘AMATO L, SABATTINI E, FEUDALE E, REYNOLDS F, GERDES J, RILKE F: J Pathol , 171 :83-98 (1993 )

12. DE BRAUD F, HEILBRUN LK, AHMED K et al: "Metastatic squamous cell carcinoma of an unknown primary localized to the neck: Advantages of an aggressive treatment." Cancer 1989; 64 :510-515

13. DIDOLKAR MS, FANOUS et al: "Metastatic carcinomas from occult primary tumors, a study of 254 patients." Ann Surg 1977 ; 186 :625-630

78

15. DONHUIJSEN K, SCHULZ S: "Prognostic significance of vimentin positivity in formalin-fixed renal cell carcinomas." Path Res Pract 184 :287-291 , 1989

16. EDER M: "Die Metastasierung: Fakten und Probleme aus humanpathologischer Sicht." Verh. Dtsch. Ges. Path . 68 , 1-11 (1984)

17. FIDLER IJ, KRIPKE ML: "Metastasis results from preexisting variant cells within a malignant tumor," Science 197 (1977 ) 893

18. FIDLER IJ, KRIPKE ML : "Metastatic heterogeneity of cells from the K-1735 melanoma. in: Metastatic Tumor Growth" , ed. E. Grundmann, Cancer Campaign Vol.4 ,Gustav Fischer Verlag , Stuttg.NY (1980 ) 71

19. FIDLER IJ, GERSTEN DM, HART IR: "The biology of cancer invasion and metastasis." Adv. Cancer Res . 28 (1978 ) 149

20. GAMBLE AR, BELL JA, RONAN J, PEARSON D, ELLIS IO: "Use of tumour marker immunreactivity to identify primary site of metastatic cancer." BMJ 1993 ;306 :295-298

21. GATTER KC, ALCOCK C, HERYET A, MASON DY: "Clinical importance of analysing malignant tumours of uncertain origin with immunohistlogical techniques. " The Lancet 1985 ;2 :1302-1305

22. GILBERT HA, KAGAN AR: "Metastases: incidence, detection and evaluation without histologic confirmation," in Weiss, L. (ed ): Fundamental aspects of metastases . New York , American Elsevier 1976 , pp 385-405

23. GRECO FA, HAINSWORTH JD: "Advanced poorly differentiated carcinoma of unknown primary site: Recognition of a treatable syndrome." Ann Intern Med 1986 ; 104: 547-556

24. GRECO FA, HAINSWORTH JD ": Cancer of unknown primary site." In Cancer: Principles & Practice of Oncology 1993 . Ed. by Vincent T. DeVita, S. Hellman, St. A. Rosenberg (J.B. Lippincott Co ., Philadelphia )

25. HAAGENSEN DE Jr, MAZOUJIAN G, DILLEY WG, PEDERSON CE, KISTER SJ, WELLS SA Jr: "Breast gross cystic disease fluid analysis: I. Isolation and radioimmunoassay for a major component protein." J Natl Cancer Inst 1979 , 62 : 239-247

79

27. HEYDEN HW, HANSEN D, KABOTH U, NAGEL GA, HOFFMANN H, SCHNEIDER B: "Metastasierendes Adenokarzinom bei unbekanntem Primärtumor" . Deutsch. med. Wschr. ,109 :15 -19 ,1984

28. HOLMES FF, FOUTS TL: "Metastatic cancer of unknown primary site" . Cancer , 26 :816-820 , 1970

29. HOLZNER JH: "Allgemeine Pathologie der Geschwülste." Urban & Schwarzenberg , München, Wien, Baltimore ,1989

30. HUFNAGL P, VOSS K: "Fidelity estimation for a hierarchical classifier." Biometr. J. 27 (1985 ), 659-667

31. JASPERSEN D: "Das CUP-Syndrom- Malignomerkrankung bei unbekanntem Primärtumor. " Fortschr Med 110.Jg . (1992 ), 31: 587-588

32. JUNGI WF, OSTERWALDER B: "Vorgehen bei Metastasen mit unbekanntem Primärtumor." Schweiz. med. Wschr . 1990 ; 120 :Nr.35 , 1273-1279

33. JORDAN WE, SHILDT RA: "Adenocarcinoma of unknown primary site." Cancer 55 :857-860 , 1985

34. KAUFMANN O, DEIDESHEIMER T, MUEHLENBERG M, DEICKE P, DIETEL M: "Immunohistochemical differentiation of metastatic breast carcinomas from metastatic adenocarcinomas of other common primary sites. " Histopathol, 1996 , 29 :233-240

35. KLÖPPEL G: "Diagnostische Schwerpunkte der Tumormarker: Gastrointestinale Tumoren." Verh. Dtsch. Ges. Path . 70 , 159-171 (1986 )

36. KOJIMA O, TAKAHASHI TT, KAWAKAMI S et al ": Localization of Estrogen receptors in gastric cancer using immunhistochemical staining of monoklonal antibody." Cancer ,1991 ,67 :2401-2406

37. KRÜGER R, LEON DE F, MAIHOFF J: "Der Wert der Immunhistochemie in der histologischen Routinediagnostik von Metastasen unbekannter Primärtumoren." Pathologe 1992, 13 :65-72

38. LE CHEVALIER T, CVITKOVIC E et al: "Early metastatic cancer of unknown primary origin at presentation." Arch intern med 1988 ; 148 : 2035-2039

39. LOY TS, CALACUCE RD: "Utility of cytokeratin immunostaining in separating pulmonary adenocarcinomas from colonic adenocarcinomas." Am J Clin Pathol 1994 ;102 :764-767

80

41. MAZOUJIAN G, PARISH TH, HAAGENSEN DE JR ": Immunperoxidase localization of GCDFP-15 with mouse monoclonal antibodies versus rabbit antiserum." J Histochem Cytochem 1988b , 36 : 377-382.

42. MENTER DG, CAVANAUGH PG, NICOLSON GL: "Adhesion and growth properties of metastatic tumour cells that colonize specific organ sites" . in : Metastasis: Basic research and ist clinical applications. ed. H. Rabes, P.E. Peters, K. Munk, Karger, 1992 -Basel-Freiburg-Paris-London-New York-New Delhi-Bangkok-Singapore-Tokyo-Sydney

43. MIZOTANI Y, TAKASHI N, MORINAGA S et al: "Immunhistochemical localization of pulmonary surfactant apoproteins in various lung tumours. Special reference to nonmucus producing lung adenocarcinomas." Cancer 1988 :61, 532-537 .

44. MOLL R, FRANKE W, SCHILLER D: "The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells." Cell 31 :11-24 (1982 )

45. MOLL R: "Epitheliale Tumormarker." Verh. Dtsch. Ges. Path . 70 :28-50 (1986 )

46. MOLL R, LÖWE A, LAUFER J, FRANKE WW: "Cytokeratin 20 in Human Carcinomas, a new histodiagnostic marker detected by monoclonal antibodies." Am J Pathol 1992 , 140 :427-446

47. MONTEAGUDO C, MERINO MJ, LA PORTE N, NEUMANN RD : Hum Pathol 22 :368-372 (1990)

48. MUIR C: "Cancer of unknown primary site" . Cancer 1995: 75 : Suppl. 353-356

49. NEDERGAARD L, HAERSLEV T, JACOBSEN G.K: "Immunhistochemical study of estrogen receptors in primary breast carcinomas and their lymph node metastases including comparison of two monoclonal antibodies." APMIS 103 :20-24 , 1995

50. NICHOLSON AG, MCCORMICK CJ, SHIMOSATO Y, BUTCHER DN, SHEPPARD MN : "The value of PE-10, a monoclonal antibody against pulmonary surfactant, in distinguishing primary and metastatic lung tumours" . Histopathol 1995 ,27 : 57-60

51. NOLTENIUS H : Tumorhandbuch, Pathologie und Klinik der menschlichen Tumoren. 2.Auflage. Urban & Schwarzenberg , München-Wien-Baltimore , 1987

81

53. NYSTROM JS, WEINER JM, WOLF RM, BATEMAN JR, VIOLA MV ": Identifying the primary site in Metastatic cancer of unknown origin." JAMA 241 :381-383 , 1979

54. OSBORN M, WEBER K: "Tumour diagnosis by intermediate filament typing: a novel tool for surgical pathology" . Lab Invest , 48: 372-381 , 1983

55. OSTEEN RT, KOPF G, WILSON RE: "In Pursuit of the unknown primary" . Am J Surg 1978 ;135 :494-498

56. PARKIN DM, MUIR GS, WHELAN S et al ( eds.): "Cancer incidence in five continents" , Vol VI ( IARC scientific publications No. 120 ) IARC , Lyon, 1993

57. PERRY A, PARISI JE, KURTIN PJ: "Metastatic adenocarcinoma to the brain: An immunohistochemical approach." Hum Pathol 1997 Aug; 28(8 ):938-43

58. RABES H, PETERS PE, MUNK K (eds"): Basic research and ist clinical applikations." Contrib. Oncol. , Vol.44 ,Karger 1992 -Basel

59. RAMAEKERS F et al: "Use of monoklonal antibodies to keratin 7 in the differential diagnosis of adenokarzinomas" . Am J Pathol , 1990 ,136 :641-655

60. RUDDON RW, NORTON SE: "Use of biological markers in the diagnosis of cancers of unknown primary tumor." Sem Oncol , 1993 Jun. 20 (3) : 251-260

61. SCHMITZ-MOORMANN P, GEBERT G, THOMAS C: Allgemeine Pathologie , ed. C. Thomas, Schattauer-Verl., Stuttgart, New York , 1995

62. SHEAHAN K, O‘BRIEN MJ, BURKE B, DERVAN PA, O‘KEANE JC, GOTTLIEB LS, ZAMCHECK N: "Differential reactivities of carcinoembryonic antigen (CEA) and CEA-related monoclonal and polyclonal antibodies in common epithelial malignancies" . Am J Clin Pathol, 1990 ;94 :157-164

63. SHLIEN S: "Nonparametric classification unsing matched binary decision trees." Patt Rec Lett (1992); 13: 83-87

64. SHIMOSATO Y, HIROHASHI S, NOGUCHI M, MATSUNO Y, TOME Y ". Recent advances in the pathological diagnosis of lung cancer. Application of monoclonal antibodies and cytofluorometry for subtyping." In: Lung cancer differentiation. Implications for diagnosis and treatment , Bernal SE, Hesketh PJ, ed. 1992 : 279-282

65. SNEE MP, VYRAMUTHU N: "Metastatic carcinoma from unknown primary site: the experience of a large oncology centre" . Br J Rad , 1985 , 58 :1091-1095

82

67. SPORN JR, GREENBERG BR: "Empiric chemotherapy in patients with carcinoma of unknown primary site." Am J Med 1990 :88 :49-55

68. STEWART JF, TATTERSALL MHN, WOODS RL, FOX RM : "Unknown primary adenocarcinoma: incidence of overinvestigation and natural history" . Br Med J, 1979 ,1 :1530-1533

69. STRNAD CM, GROSH WW, BAXTER J, BURNETT LS, JONES HW, GRECO FA, HAINSWORTH JD: "Peritoneal Carcinomatosis of unknown primary site in women." Ann Intern Med . 1989 ; 111 :213-217

70. TRUE LD "a) Epithelial membrane antigens b) Sex steroid hormone rezeptors." In: Atlas of diagnostic immunohistopathology. Ed. L.D. True, J.B. Lippincott company , 1990 , Philadelphia, New York, London

71. WICK MR, LILLEMOE TJ, COPLAND GT et al: "Gross cystic disease fluid protein-15 as a marker for breast cancer. Immunohistochemical analysis of 690 human neoplasms and comparison with alpha-lactalbumin." Hum Pathol 20 :281-287 , 1989

72. WILLIS RA : The spread of tumours in the human body . 3. Ed. Butterworth & Co , 1973

© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.